This finding positions FXYD3, a protein traditionally associated with ion channel regulation, at the crossroads of cancer‐related inflammation and innate immune signaling, thereby providing a new paradigm for understanding the pathogenesis of ICC. The gene discussed is FXYD3; the disease is cancer.